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Background and aims Breath hydrogen testing after lactulose administration may yield findings of clinical value, but whether it should be a routine part of breath testing has not been evaluated. We examined the contribution of breath testing after lactulose administration to the conduct and interpretation of breath hydrogen responses after fructose and lactose administration.
Methods Two hundred consecutive patients were given lactulose, fructose or lactose on separate days (at least 2 days apart); breath hydrogen was monitored every 15 min after the administration of each sugar.
Results Peak breath hydrogen levels after lactulose administration correlated with those after fructose (r = 0.26; P = 0.03) and lactose (r = 0.44; P = 0.004). Of the patients with a reduced response to lactulose, 51% had definite or borderline evidence of fructose malabsorption (FM); similarly, 23% of patients had definite or borderline lactose malabsorption. After lactulose administration, an increase in breath hydrogen levels occurred after the same amount of time or longer than after the administration of fructose or lactose ( > 120 min). The earlier the first rise in breath hydrogen levels after lactulose administration, the more frequently FM occurred, indicating an association between FM and rapid transit and/or small intestinal bacterial overgrowth.
Conclusion Routine breath hydrogen testing with lactulose administration before other sugars cannot be used to define non-hydrogen producers, but might, by indicating the vigour of hydrogen production in the individual, allow more rational interpretation of results after testing with other sugars. It permits the duration of testing to be judged and provides information on possible mechanisms of FM. Eur J Gastroenterol Hepatol 
Introduction
There has been a resurgent interest in breath hydrogen testing with recognition of first, the symptomatic benefit of restricting dietary lactose and/or free fructose, if malabsorption of either is demonstrated [1] [2] [3] [4] and second, the putative value of demonstrating small intestinal bacterial overgrowth (SIBO) in patients with functional gut symptoms [5, 6] . One of the many unresolved issues associated with breath hydrogen tests is whether determining the response to lactulose should be routinely performed on all patients, or whether it should be applied selectively in specific clinical scenarios.
Lactulose is a synthetic disaccharide of fructose and galactose for which no hydrolase is present in the human small intestine. An oral load of lactulose will, therefore, always be malabsorbed and delivered to intestinal bacteria, which rapidly ferment it. Some people do not produce a measurable breath hydrogen response to intestinal carbohydrate fermentation because of efficient utilization of hydrogen by methanogens, sulphate-reducing bacteria and/or acetogens. The response to lactulose has, therefore, been used as a positive control in breath hydrogen testing to determine whether the individual being tested is a 'non-hydrogen producer' (NHP). It has also been used to determine whether the individual is a methane producer, an alternative to hydrogen in NHPs. Alternatively, lactulose might potentially be used to determine how vigorous the breath hydrogen response is in an individual. This may help interpret the significance of equivocal rises in breath hydrogen after, for example, the ingestion of fructose or lactose.
The lactulose breath test has also been used to provide other physiological information. The time between its ingestion and the first rise in breath hydrogen has been used to measure orocaecal transit time [7, 8] , although lactulose itself may hasten orocaecal transit [9] , and to define patients with SIBO [10] . Although an early rise in breath hydrogen after lactulose (ERBHAL) administration is usually linked to SIBO, distinguishing this from fast orocaecal transit may require retesting after antibiotic therapy [11] . A late rise in breath hydrogen indicates slow transit.
The aim of this study was, therefore, to examine the contribution of lactulose breath testing to the interpretation of breath hydrogen responses to fructose and lactose in a consecutive series of patients referred for testing.
Methods

Patients
To avoid selection bias, the results from breath hydrogen tests carried out on 200 consecutive patients in the Gastrointestinal Physiology Service of Box Hill Hospital were reviewed, irrespective of whether complete clinical information was present or not. Most patients were referred by general practitioners or gastroenterologists. Local practice is for patients with functional gastrointestinal symptoms to have breath hydrogen testing before counselling by a dietitian to reduce the intake of dietary FODMAPs (fermentable oligo-, di-and monosaccharides and polyols; poorly absorbed short-chain carbohydrates) [1, 3, 12] . The purpose of breath testing is to identify patients who can completely absorb a load of fructose and lactose, so that these do not require specific attention in the design of the diet taught. Information on the underlying symptom complex or disease was obtained from referral information provided, medical histories of patients attending clinics at Box Hill Hospital, or detailed symptom questionnaires that patients are routinely asked to fill out before testing. 
Breath test methodology
After dietary restriction of fermentable substrates for at least 24 h and an overnight fast, patients underwent breath hydrogen tests, first with the ingestion of 15 g lactulose, then 35 g fructose and/or 50 g lactose (each in 200 ml water) on separate days, at least 2 days apart. Breath hydrogen was measured before and every 15 min (for at least 2 h) after the ingestion of each sugar using a hand-held breath hydrogen monitor (Bedfont Gastrolyzer; Air-Met Scientific, Nunawading, Victoria, Australia). Patients who failed to produce breath hydrogen 90 min after the ingestion of lactulose, had breath samples collected into bags for subsequent measurement of hydrogen and methane content in a SC Microlyzer (Quintron Instrument Co., Milwaukee, Wisconsin, USA).
Breath test result interpretation
All results were evaluated by a gastroenterologist (P.M.I.), reporting in terms of definite or borderline fructose malabsorption (FM) or lactose malabsorption (LM); no response or a blunted response to lactulose; and an ERBHAL according to the definitions outlined in Table 1 . The first 139 patients were also independently reported by another gastroenterologist (P.R.G.) to determine the interobserver variation in the use of the definitions. Disagreement was minimal. The analysis of the data was then undertaken by an independent investigator (J.P.B.).
Statistical evaluation
Data were analysed descriptively. Comparisons between groups were performed using either the Fisher's exact test or the Mann-Whitney U test where appropriate. Correlations were calculated using the Spearman's test. Analyses were performed using GraphPad Prism (version 3.00 for Windows; GraphPad Software, San Diego California, USA; www.graphpad.com). All tests were two-tailed and a P value r 0.05 was considered as significant.
Results
Patients
There were 150 female patients (75%) and the mean age was 39 (range 5-88) years. Sufficient detailed information was available on 108 patients to classify patients according to the Rome III criteria [13] : 69 had irritable bowel syndrome (14 with constipation, 22 with diarrhoea, Table 1 Definitions applied in the interpretation of breath test results
Hydrogen Methane
Fructose malabsorption Z 10 ppm over baseline on two consecutive occasions Z 20 ppm over baseline on two consecutive occasions Lactose malabsorption Z 10 ppm over baseline on two consecutive occasions Z 20 ppm over baseline on two consecutive occasions Borderline fructose malabsorption 5-9 ppm over baseline on two consecutive occasions or Z 10 ppm over baseline on one occasion with hydrogen production in one adjacent measurement 15-19 ppm over baseline on two consecutive occasions or Z 20 ppm over baseline on one occasion with methane production in one adjacent measurement Borderline lactose malabsorption 5-9 ppm over baseline on two consecutive occasions or Z 10 ppm over baseline on one occasion with hydrogen production in one adjacent measurement 15-19 ppm over baseline on two consecutive occasions or Z 20 ppm over baseline on one occasion with methane production in one adjacent measurement Non-hydrogen/non-methane producer < 10 ppm over baseline or Z 10 ppm over baseline on one occasion without hydrogen production in adjacent measurements < 20 ppm over baseline or Z 20 ppm over baseline on one occasion without methane production in adjacent measurements Blunted response to lactulose 10-19 ppm over baseline on two consecutive occasions or 10-19 ppm over baseline on one occasion with hydrogen production in one adjacent measurement 20-29 ppm over baseline on two consecutive occasions or 20-29 ppm over baseline on one occasion with methane production in one adjacent measurement Early hydrogen rise Z 10 ppm on two consecutive occasions both before 90 min Z 20 ppm on two consecutive occasions both before 90 min 16 mixed and 17 unsubtyped), 16 had functional bloating, seven had functional constipation, five had functional diarrhoea and 11 had unspecified functional bowel disorder. Two patients had functional oesophageal disorder, one had functional bloating with treated coeliac disease and two had functional gastrointestinal symptoms with Crohn's disease in remission. The remaining 87 patients had combinations of functional gastrointestinal symptoms (bloating, altered bowel habit, abdominal pain or discomfort), but insufficient specific data were available to apply the Rome criteria.
Breath responses to fructose, lactose and lactulose
The number of patients tested with lactulose, fructose and lactose and the key results are shown in Table 2 .
Using the criteria outlined in Table 1 , 52% of those tested had definite or borderline FM and 36% definite or borderline LM; 15% had both using definite criteria and 38% neither. Failure to produce hydrogen in response to lactulose occurred in 20 patients (10%) and, of those, nine did not produce methane.
All those with FM or LM had their first rise in breath hydrogen by 210 and 165 min, respectively. The times of first rise of breath hydrogen after the sugars are shown in Fig. 1 . The pattern of first rise in breath hydrogen after lactulose administration was within the normal range in 51%; 22% had ERBHAL and 17% had a late rise ( Table 2) .
Relationship of the response to lactulose with response to fructose and lactose
As shown in Fig. 2 , the peak breath hydrogen response to lactulose significantly correlated with the peak Nineteen of the 20 patients who did not produce hydrogen in response to lactulose were tested for FM and the same number for LM. The results are shown in Fig. 3 . Despite the lack of response to lactulose, 10 (53%) had a diagnostic or borderline breath hydrogen response after fructose administration and eight (42%) after lactose administration. Six (33%) patients had both FM and LM (definite or borderline). Only three patients with no breath hydrogen response to lactulose were diagnosed with FM and/or LM on methane testing. Three with a borderline hydrogen response to fructose and two with a borderline response to lactose, had a diagnostic response with methane.
Of the 38 patients with a blunted response to lactulose, 19 (51%) of the 37 tested with fructose had definite or borderline evidence of FM. Of the 18 patients with no response to fructose on the predefined criteria, eight (44%) had no breath hydrogen rise above baseline at all, but four (22%) had a peak rise of 1-4 ppm and six (33%) had a peak rise of 5-9 ppm. Likewise, eight (23%) of the 35 patients who had a blunted response to lactulose had definite or borderline LM. Of the 27 remaining patients who had no diagnostic or borderline response to lactose, six (22%) had no rise above baseline, 17 (63%) had a peak rise of 1-4 ppm and four (15%) a peak rise of 5-9 ppm. The relationship between peak breath hydrogen levels after lactulose administration with those after fructose administration in fructose malabsorbers and lactose administration in lactose malabsorbers. Levels correlated significantly with the Spearman's correlation coefficients being 0.26 (P = 0.03) and 0.44 (P = 0.004), respectively. FM (4) Response to methane (2) Borderline response to methane (1) Borderline response to methane (0)
Response to methane (1) No response to methane (9) No response to methane (7) Tested with fructose (19) Tested with lactose (19) Non-hydrogen producers (20) Borderline FM (6) No response (9) No response (11) LM (6) Borderline LM (2) Breath hydrogen and methane responses in patients who failed to produce a breath hydrogen response to lactulose (non-hydrogen producers). FM, fructose malabsorption; LM, lactose malabsorption. Seven (21%) of the 34 patients tested with both sugars and with a blunted response to lactulose had both FM and LM (definite or borderline).
The contribution of breath testing after lactulose administration to the overall interpretation of hydrogen patterns after fructose and lactose administration is shown in Table 3 . More patients were diagnosed with FM and/or LM (112 compared with 89; P = 0.01) when nondiagnostic responses (hydrogen rise of 5-9 ppm above baseline) were interpreted in association with the responses after lactulose administration (non-hydrogen production or a blunted response) and taken as evidence of malabsorption. Furthermore, the use of hydrogen responses to lactulose deemed the lack of response after fructose or lactose as noninformative in many patients; without such information, the results would be interpreted as showing no evidence of FM and/or LM.
Relationship of the time of first rise of breath hydrogen after lactulose administration to the time of first rise after fructose and lactose administration
The median time of first rise in breath hydrogen after fructose administration was significantly earlier (P < 0.0001) than that for lactulose, and tended to be earlier (P = 0.06) for lactose ( Fig. 4) .
The frequency of malabsorption varied with the time of the first rise in breath hydrogen after lactulose or fructose administration but not after lactose administration (Table 4 ). The proportion of patients with FM was significantly greater in those with early rises in response to lactulose compared with those with normal and late rises (P = 0.02 and 0.002, respectively; Fisher's exact test). The proportion of patients with both FM and LM was lower in people with a late rise than an early rise in breath hydrogen (P = 0.004). The relationship of the time of first rise in breath hydrogen after lactulose administration with that after fructose and lactose administration. The median time of first rise in breath hydrogen after fructose administration was significantly earlier than that for lactulose (P < 0.0001; Mann-Whitney U test) and tended to be earlier for lactose (P = 0.06). 
Discussion
This study addressed issues important in the interpretation of breath hydrogen tests, which have attracted a resurgence of interest. The routine use of lactulose in breath hydrogen test regimens has an appeal that, as a positive control, it might give useful information on the vigour of hydrogen responses to a malabsorbed sugar. This aids the interpretation of subsequent testing with fructose, lactose or glucose. Exhalation of hydrogen is only one of the disposal routes for molecules generated by bacterial fermentation in the intestine; excretion may also occur through methane production, use in sulphate reduction and incorporation into acetic acid. Indeed, in the current series of 200 consecutive patients, the breath hydrogen response to lactulose varied widely with 10% having no response and a further 19% a blunted response.
Such a variance raises the important question of what
absolute change in breath hydrogen should be used as the cutoff value between a positive and negative result [14] , and whether this cutoff value should vary between individuals. Many investigators have used 20 or 15 ppm as a significant change, but at least one group has shown that 10 ppm is appropriate [15] [16] [17] [18] . Given the accuracy of the detection systems used, a rise of 10 ppm over baseline is reasonable for most people, provided it is sustained over two adjacent measurements, as occasional isolated high levels can be seen.
The concentration of hydrogen in the breath after the ingestion of a single sugar, such as fructose, does not indicate the proportion of that sugar that is malabsorbed. It has been proposed instead that the ratio of the area-under-the-curve for a sugar compared with that for a positive control could reasonably be used to determine semiquantitatively the degree of malabsorption [19] . However, breath tests for FM or LM are carried out not to determine what proportion of sugar is malabsorbed, but whether the individual can fully absorb a load of that sugar [12, 20] . This information is then used to determine whether dietary restriction of free fructose or lactose should be applied in managing functional gut symptoms [21] . Thus, the determination of the lack of malabsorption, rather than its presence, is the key information being sought.
The peak breath hydrogen levels after lactulose administration correlated with those after fructose and lactose in patients with FM and LM, respectively. It is, therefore, proposed that the magnitude of the breath hydrogen response to lactulose can be used to better interpret responses to the sugars of interest, particularly if the responses to all sugars are small. In this study, nearly one-third of the patients had an absent or blunted response to lactulose. Using this information, the confidence with which the breath test is interpreted as showing complete absorption of fructose and lactose could be improved. Thus, a patient with a very small response to lactulose who then has, for example, a 7 ppm peak rise after fructose cannot be considered to have no evidence of FM. In fact, assuming these patients do indeed have malabsorption, the overall proportion of patients with FM and LM is significantly higher. However, at present, it is unclear whether it is clinically advantageous to manage these patients as having FM and/or LM. In addition, a blunted or absent hydrogen response to lactulose will enable noninformative studies to be identified. Thus, in such a case, the absence of a hydrogen response after fructose or lactose administration will indicate that the test is not helpful in determining the status of FM or LM in the individual. Without the lactulose data, the patient would be deemed to have complete fructose and lactose absorption.
The result of this study also raises doubt about the concept of a 'non-hydrogen producer' as determined by lactulose breath testing. More than half of the patients without a response, or with a blunted response, to lactulose, had definite or borderline FM and/or LM. Clearly, these patients are not NHPs and perhaps the demonstration of FM and LM in those without a rise in breath hydrogen after lactulose administration can be explained by the amount of sugar available for fermentation. Such a potential exists as the doses of fructose (35 g) and lactose (50 g) were higher than that of lactulose (15 g) and if either of the first two sugars were not absorbed at all, larger amounts of carbohydrate will be presented to bacteria that may not be particularly vigorous hydrogen producers (as indicated by low or undetectable responses to lactulose). Alternatively, fructose and lactose might be more rapidly fermented or preferentially fermented by different bacterial populations. There are, however, no data to support this contention. Thus, a lactulose breath test cannot be used to screen patients regarding whether they are NHPs or to determine whether subsequent testing should proceed. It may, however, help to interpret the response to fructose and lactose.
The dose of sugar chosen for breath testing depends upon the question being asked. Lactulose has been applied at varying doses, from 10 to 20 g [6, [22] [23] [24] [25] [26] [27] . Large doses would minimize the problem of blunted responses observed in this study, but would have significant potential disadvantages. For example, a large dose may accelerate gastric emptying and small intestinal transit, and may have an exaggerated laxative effect by the virtue of its minimal absorption [28] , particularly in the target population with functional gastrointestinal disorders. In examining the activity of lactase, it is appropriate to use a large dose (50 g) to test the hydrolytic capacity of that enzyme [29] . However, for fructose it is not the activity of a hydrolase that is being examined but the absorptive capacity of the small intestine, which is limited for free fructose. Therefore, a dietitian needs to know whether an individual can completely absorb a load of fructose that might be encountered in a normal diet. A variety of doses have been applied in published studies [30] and, as might be expected, the proportion of the population who can completely absorb a load of fructose diminishes as the dose increases. As few as 20% of those tested will completely absorb a 50 g load, whereas this can be as high as 80% for 25 g. The dietary equivalents of these doses are shown in Table 5 . It seems that 35 g, as used in our study, is a realistic upper limit of normal dietary intake and should, therefore, differentiate patients where FM might contribute to the genesis of symptoms. However, no studies have been carried out to compare clinical outcomes from dietary change when complete fructose absorption is defined by, for example, a load of 20 versus 35 g.
Routinely, testing the response to lactulose in patients undergoing tests for FM or LM has other potential advantages. The pattern of breath hydrogen production, particularly its time of first rise, might also give insight into transit time. On a practical note, this information is useful in determining the duration of subsequent breath tests. We have demonstrated that it is rare for the first rise of breath hydrogen after fructose or lactose administration to occur after that of lactulose administration. This is of particular relevance to those with a late rise (later than 120 min) where the hydrogen responses would have been missed if the standard protocol of 120 min of testing after ingestion of the sugar was followed.
Breath hydrogen responses to fructose start significantly earlier than those for lactulose and lactose, and this finding in our study might be explained by rapid gastric emptying [42] and possibly more rapid intestinal transit. Lactulose will accelerate orocaecal transit by the effects on small bowel transit [43] , and therefore cannot be used to accurately measure the physiological transit time. However, an ERBHAL has been used as a marker of SIBO. The demonstration that functional gut symptoms in patients with ERBHAL respond to dietary (elemental diet) [44] and antibiotic regimens [45] suggests that information regarding ERBHAL may direct therapeutic strategies. That ERBHAL represents SIBO rather than rapid transit is supported by the delay in the first rise in the majority of patients after such treatment [46] .
A further controversy is in the nomenclature that is used in interpreting the results of breath tests. It has been argued that the term 'malabsorption' should not be applied in situations where a positive fructose breath test is associated with SIBO, as the breath test may become negative after the use of antibiotics [46] . However, if fructose is fermented by bacteria before its absorption, then it seems reasonable to call this 'fructose malabsorption' whether the bacteria responsible live in the small or large intestine. Thus, lactulose breath testing may give additional insights into the mechanism by which FM is present.
A failure to absorb fructose may be because of early exposure to bacteria (such as in SIBO) or low capacity of small intestinal transport mechanisms, alone or in combination [30] , as indicated by our finding of an association between FM and ERBHAL. However, given that ERBHAL was not associated with the failure to completely absorb lactose, lactase deficiency (as opposed to SIBO) seems to be the underlying mechanism in the vast majority of patients with LM.
Hydrogen seems to be a better marker of bacterial fermentation than methane, as methanogens tend to populate the more distal large bowel. Although about three quarters of the population carry the latter bacteria, not all of them produce methane in amounts detectable in the breath [47, 48] . The site of methanogens colonization along with the rapidity of sugar fermentation suggests that hydrogen production is a reliable measure across groups and that methane status does not affect hydrogen production, but this has not been formally tested. Concurrent methane measurement may offer potential advantages [49, 50] , especially in those who do not have a hydrogen response. However, almost one in two NHPs was also a non-methane producer. Therefore, the yield of using methane (in those who do not produce hydrogen in response to lactulose) was very small (only three additional patients were diagnosed with either FM or LM), especially if borderline hydrogen responses to fructose or lactose are interpreted as outlined above. In some laboratories, methane is routinely measured, but many now use cost-effective hand-held instruments, which detect hydrogen alone. It is reassuring that few positive results will be missed by this practice.
In conclusion, this study has shown that breath hydrogen testing with lactulose before testing with other sugars offers several benefits. It indicates the ability of bacteria Table 5 Fructose dose equivalence in food intake Fructose dose Equivalence in food intake References 1-2 g/kg For 60 kg person, 1-2 l apple juice [16,31] 50 g 850 ml apple juice; or 400 ml apple juice plus enough honey to generously cover three slices of toast; or One can of US soft drink (high fructose corn syrup), one pear, one apple and one slice of toast with honey [32] [33] [34] [35] [36] [37] [38] [39] 35 g 300 ml apple juice and one pear; or 300 ml apple juice and one slice of toast with honey [3] 25 g 300 ml apple juice; or One apple and one pear [40, 41] 
g
One can of US soft drink [20] in the individual to generate a hydrogen response, permitting more rational interpretation of subsequent breath hydrogen results after fructose and lactose administration. It also permits the duration of testing to be judged, saving time in many and ensuring that late rises are not missed in others. Finally, it provides the information on the potential SIBO that may offer clues to the cause of FM and be of clinical value in designing therapy. The addition of breath methane assessment offers only marginal benefits. It is recommended that lactulose be tested first, before other sugars, in routine practice.
